Quantification revealed 43.9 ± 4.6% of GFAP+ astrocytes with nuclear GR staining in control samples compared to 16.4 ± 3.4% for PD samples indicating that number of astrocytes with nuclear GR expression is significantly reduced in PD patients. Here, NR3C1 is linked to Parkinson disease.